Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 1, 2000.
Copyright & Usage
© 2000
Author Information
- John M. Hoffman,
- Kathleen A. Welsh-Bohmer,
- Michael Hanson,
- Barbara Crain,
- Christine Hulette,
- Nancy Earl and
- R. Edward Coleman
- National Cancer Institute, Bethesda, Maryland; Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University, Durham; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; Department of Radiology, Duke University Medical Center, Durham, North Carolina; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; and Department of Pathology, Duke University Medical Center, Durham, North Carolina
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- BOLD Amplitude Correlates of Preclinical Alzheimers Disease
- A machine-learning approach for detection of local brain networks and marginally weak signals identifies novel AD/MCI differentiating connectomic neuroimaging biomarkers
- Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimers disease
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- Brain imaging in dementia
- Biomarkers in dementia: clinical utility and new directions
- Association of hypometabolism and amyloid levels in aging, normal subjects
- Diagnostic tests for Alzheimer disease: Judicious use can be helpful in clinical practice
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
- Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies
- Brain Imaging in Alzheimer Disease
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
- A tale of two tracers: The age of wisdom for dementia diagnosis?
- Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients
- Effects of Age on the Glucose Metabolic Changes in Mild Cognitive Impairment
- Imaging Approaches to Parkinson Disease
- What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
- Comparison of Regional Brain Volume and Glucose Metabolism Between Patients with Mild Dementia with Lewy Bodies and Those with Mild Alzheimer's Disease
- Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
- APOE related alterations in cerebral activation even at college age
- Brain 18F-FDG PET in the Diagnosis of Neurodegenerative Dementias: Comparison with Perfusion SPECT and with Clinical Evaluations Lacking Nuclear Imaging
- Evaluating Early Dementia With and Without Assessment of Regional Cerebral Metabolism by PET: A Comparison of Predicted Costs and Benefits
- Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer's Disease
- SPECT Imaging in Dementias
- Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
- A Tabulated Summary of the FDG PET Literature
- Evaluating Dementia Using PET: How Do We Put into Clinical Perspective What We Know to Date?